1
|
Rodríguez-Mayor AV, Peralta-Camacho GJ, Cárdenas-Martínez KJ, García-Castañeda JE. Development of Strategies for Glycopeptide Synthesis: An Overview on the Glycosidic Linkage. CURR ORG CHEM 2020. [DOI: 10.2174/1385272824999200701121037] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Glycoproteins and glycopeptides are an interesting focus of research, because of
their potential use as therapeutic agents, since they are related to carbohydrate-carbohydrate,
carbohydrate-protein, and carbohydrate-lipid interactions, which are commonly involved in
biological processes. It has been established that natural glycoconjugates could be an important
source of templates for the design and development of molecules with therapeutic applications.
However, isolating large quantities of glycoconjugates from biological sources
with the required purity is extremely complex, because these molecules are found in heterogeneous
environments and in very low concentrations. As an alternative to solving this
problem, the chemical synthesis of glycoconjugates has been developed. In this context,
several methods for the synthesis of glycopeptides in solution and/or solid-phase have been
reported. In most of these methods, glycosylated amino acid derivatives are used as building
blocks for both solution and solid-phase synthesis. The synthetic viability of glycoconjugates is a critical parameter
for allowing their use as drugs to mitigate the impact of microbial resistance and/or cancer. However, the
chemical synthesis of glycoconjugates is a challenge, because these molecules possess multiple reaction sites and
have a very specific stereochemistry. Therefore, it is necessary to design and implement synthetic routes, which
may involve various protection schemes but can be stereoselective, environmentally friendly, and high-yielding.
This review focuses on glycopeptide synthesis by recapitulating the progress made over the last 15 years.
Collapse
|
2
|
Rojas-Ocáriz V, Compañón I, Aydillo C, Castro-Loṕez J, Jiménez-Barbero J, Hurtado-Guerrero R, Avenoza A, Zurbano MM, Peregrina JM, Busto JH, Corzana F. Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety. J Org Chem 2016; 81:5929-41. [PMID: 27305427 DOI: 10.1021/acs.joc.6b00833] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The use of vaccines based on MUC1 glycopeptides is a promising approach to treat cancer. We present herein several sulfa-Tn antigens incorporated in MUC1 sequences that possess a variable linker between the carbohydrate (GalNAc) and the peptide backbone. The main conformations of these molecules in solution have been evaluated by combining NMR experiments and molecular dynamics simulations. The linker plays a key role in the modulation of the conformation of these compounds at different levels, blocking a direct contact between the sugar moiety and the backbone, promoting a helix-like conformation for the glycosylated residue and favoring the proper presentation of the sugar unit for molecular recognition events. The feasibility of these novel compounds as mimics of MUC1 antigens has been validated by the X-ray diffraction structure of one of these unnatural derivatives complexed to an anti-MUC1 monoclonal antibody. These features, together with potential lack of immune suppression, render these unnatural glycopeptides promising candidates for designing alternative therapeutic vaccines against cancer.
Collapse
Affiliation(s)
- Víctor Rojas-Ocáriz
- Departamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , Madre de Dios 53, 26006 Logroño, Spain
| | - Ismael Compañón
- Departamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , Madre de Dios 53, 26006 Logroño, Spain
| | - Carlos Aydillo
- Departamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , Madre de Dios 53, 26006 Logroño, Spain
| | - Jorge Castro-Loṕez
- BIFI, University of Zaragoza, BIFI-IQFR (CSIC) Joint Unit , Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, Zaragoza, Spain
| | - Jesús Jiménez-Barbero
- Structural Biology Unit, CIC bioGUNE , Parque Tecnológico de Bizkaia Building 801 A, 48160 Derio, Spain.,IKERBASQUE, Basque Foundation for Science , 48011 Bilbao, Spain.,Department of Chemical and Physical Biology, Centro de Investigaciones Biológicas , CSIC Ramiro de Maeztu 9, 28040 Madrid, Spain
| | - Ramón Hurtado-Guerrero
- BIFI, University of Zaragoza, BIFI-IQFR (CSIC) Joint Unit , Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, Zaragoza, Spain.,Fundación ARAID , 50018 Zaragoza, Spain
| | - Alberto Avenoza
- Departamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , Madre de Dios 53, 26006 Logroño, Spain
| | - María M Zurbano
- Departamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , Madre de Dios 53, 26006 Logroño, Spain
| | - Jesús M Peregrina
- Departamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , Madre de Dios 53, 26006 Logroño, Spain
| | - Jesús H Busto
- Departamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , Madre de Dios 53, 26006 Logroño, Spain
| | - Francisco Corzana
- Departamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , Madre de Dios 53, 26006 Logroño, Spain
| |
Collapse
|